Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience

被引：0

作者：

Conti, Andrea ^{[1
]}

Galdo, Giovanna ^{[1
]}

Greco, Maurizio ^{[1
]}

Borsari, Stefania ^{[1
]}

Lasagni, Claudia ^{[1
]}

机构：

[1] Azienda Osped Univ Policlin Modena, SC Dermatol, I-41124 Modena, Italy

来源：

CLINICAL DRUG INVESTIGATION | 2013年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S84 / S86

页数：3

共 10 条

[1] CONTINUOUS TREATMENT OF PLAQUE-TYPE PSORIASIS WITH ETANERCEPT: AN OBSERVATIONAL LONG-TERM EXPERIENCE [J].

Esposito, M. ;

Giunta, A. ;

Mazzotta, A. ;

Babino, G. ;

Talamonti, M. ;

Chimenti, M. S. ;

Chimenti, S. .

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (02) :503-509

[2] Etanercept as monotherapy in patients with psoriasis [J].

Leonardi, CL ;

Powers, JL ;

Matheson, RT ;

Goffe, BS ;

Zitnik, R ;

Wang, A ;

Gottlieb, AB ;

Bagel, J ;

Camisa, C ;

Caro, I ;

DiGiovanna, JJ ;

Dunlap, FF ;

Elewski, BE ;

Gribetz, CE ;

Farber, HF ;

Feldman, SR ;

Frankel, EH ;

Gaspari, AA ;

Goodman, JJ ;

Gordon, KB ;

Hampel, FC ;

Herdener, RS ;

Hoffman, MD ;

Humeniuk, JM ;

Johnson, SM ;

Kang, S ;

Kimball, AB ;

Kirsner, RS ;

Korman, NJ ;

Krueger, GG ;

Kuwahara, RT ;

Lebwohl, M ;

Ling, MR ;

Liu, DC ;

Lowe, N ;

McCall, CO ;

Menter, A ;

Miller, BH ;

Moore, JK ;

Nayak, AS ;

Ratner, PH ;

Savin, RC ;

Shupack, JL ;

Smith, SL ;

Stone, SP ;

Swinehart, JM ;

Taborn, J ;

Tschen, EH ;

Weinstein, GD ;

Werth, VP .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :2014-2022

[3]

Leonardi C, 2010, J DRUGS DERMATOL, V9, P928

[4] A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction [J].

Papp, KA ;

Tyring, S ;

Lahfa, M ;

Prinz, J ;

Griffiths, CEM ;

Nakanishi, AM ;

Zitnik, R ;

van de Kerkhof, PCM .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) :1304-1312

[5]

Papp Kim A, 2012, J Am Acad Dermatol, V66, pe33, DOI 10.1016/j.jaad.2010.07.026

[6] Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists [J].

Paul, C. ;

Gallini, A. ;

Maza, A. ;

Montaudie, H. ;

Sbidian, E. ;

Aractingi, S. ;

Aubin, F. ;

Bachelez, H. ;

Cribier, B. ;

Joly, P. ;

Jullien, D. ;

Le Maitre, M. ;

Misery, L. ;

Richard, M-A ;

Ortonne, J-P .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 :2-11

[7] Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials [J].

Reich, K. ;

Burden, A. D. ;

Eaton, J. N. ;

Hawkins, N. S. .

BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (01) :179-188

[8] Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry [J].

Tubach, F. ;

Salmon, D. ;

Ravaud, P. ;

Allanore, Y. ;

Goupille, P. ;

Breban, M. ;

Pallot-Prades, B. ;

Pouplin, S. ;

Sacchi, A. ;

Chichemanian, R. M. ;

Bretagne, S. ;

Emilie, D. ;

Lemann, M. ;

Lorthololary, O. ;

Mariette, X. .

ARTHRITIS AND RHEUMATISM, 2009, 60 (07) :1884-1894

[9] Safety of treatment with biologics for psoriasis in daily practice: 5-year data [J].

van Lumig, P. P. M. ;

Driessen, R. J. B. ;

Berends, M. A. M. ;

Boezeman, J. B. M. ;

van de Kerkhof, P. C. M. ;

de Jong, E. M. G. J. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (03) :283-291

[10] Long-term safety and efficacy of etanercept in the treatment of psoriasis [J].

Zaragoza, V. ;

Perez, A. ;

Sanchez, J. L. ;

Oliver, V. ;

Martinez, L. ;

Alegre, V. .

ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (01) :47-53

← 1 →